Crescendo Biologics’ CEO, Peter Pack to present and participate in panel at Biotech and Money 2017

Crescendo Biologics’ CEO, Peter Pack to present and participate in panel at Biotech and Money 2017

view PDF

Crescendo Biologics partners with software-provider, Genedata, on next-generation immuno-oncology and ADC programs

Crescendo Biologics partners with software-provider, Genedata, on next-generation immuno-oncology and ADC programs.

view PDF

Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m

Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m
view PDF